Your SlideShare is downloading. ×
0
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Coagulation CME 2007
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Coagulation CME 2007

991

Published on

Published in: Education, Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
991
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
30
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Coagulation
  • 2. Blood clot
    • Platelets (150 - 400K)
      • Activated by collagen, thrombin, etc.
      • Release platelet and coagulation factors
    • Insoluble fibrin molecules
      • Prothrombin is converted to thrombin
      • Thrombin binds soluble fibrin into insoluble mesh
  • 3.  
  • 4.  
  • 5. Controlling Clotting
    • AntithrombinIII: inhibits the formation of thrombin by binding to and in activating:
      • • prothrombin
      • • factor 9
      • • factor 10
    • Heparin is a mixture of polysaccharides that bind to antithrombin III & enhance inhibition of thrombin synthesis.
      • prothombin (Factor II) to Thrombin
  • 6. Vitamin K
    • Vitamin K is required (as a cofactor) for the body to make four of the blood's coagulation (clotting) factors: particularly prothrombin and also factors VII, IX, and X
    • K was for Koagulation (Danish for coagulation)
  • 7. Coumadin (Warfarin)
  • 8. Prothrombin time, PT Coumadin/warfarin
    • PT reflects the depression of vitamin K dependent Factors VII, X and II.
    • A system of standardizing the PT International Normalized Ratio (INR) provides a common basis for communication of PT results and interpretations of therapeutic ranges
      • 1 is baseline (normal), 2-3.5 is therapeutic
  • 9. Activated Partial Thromboplastin Time Heparin inactivates factor II, prothrombin
    • Evaluates function of
      • Intrinsic (XII, XI, IX, VII)
      • Common(V, X, II, I)
    • Used to evaluate heparin therapy
    • Also used as first step evaluation of coagulopathy.
  • 10. Standard heparin (Unfractionated)
    • Variety of molecule lengths.
    • Smaller molecules much more effective.
    • Must test, PTT, for therapeutic level.
  • 11. Low molecular weight heparin Lovenox,
    • More consistent dosing
    • No need to test PTT
    • SQ administration, twice daily
    • Costs more
    • Lower rates of HIT
  • 12. Heparin induced thrombocytopenia
    • Decrease in platelet count
    • Increased risk of arterial and venous thrombosis
    • DVT risk is most common complication
    • Type I, 10 to 20% of heparinized patients, PLTs fall 50% but rarely under 100K
    • Type II rare but serious autoimmune disorder.
  • 13. Thrombolytics
    • Tissue plasminogen activator (TPA)
    • Dissolves existing blood clots
    • Therapeutic for Ischemic heart disease and strokes
    • Risk of bleeding
  • 14.  
  • 15. What does this have to do with EMS?
  • 16.
    • Recognize symptoms of stroke
    • Transport to Appropriate facility
    • Consider effect of Anticoagulant therapy with patients with falls and head trauma
  • 17.
    • AIRWAY

×